Abstract
BackgroundRituximab (RTX) is a chimeric monoclonal antibody that targets the CD20 antigen expressed at the B cell surface. It was first used for the treatment of non-Hodgkin's lymphoma and then...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have